{
    "medicine_id": "b6e6b447b7c48993e2f9fd18e01a7fe2bf14d8c0",
    "platform_id": "DB13165",
    "metadata": {
        "name": "Pastilles Valda 2 mg Tablet coated",
        "composition": "2 mg Ripasudil",
        "clinical_particulars": {
            "therapeutic_indications": "Ripasudil has been proven to be effective in the twice daily treatment of glaucoma and ocular hypertension It is currently in studies to be approved for both diabetic retinopathy and diabetic macular oedema",
            "contraindications": {
                "disease": "The most frequent adverse effect of Ripasduil is mild to moderately severe conjunctival hyperemia which was found to cease spontaneously within hours Mild conjunctival follicles were also reported which also were spontaneously resolved Other adverse effects include ocular irritation an abnormal sensation in the eye and conjunctival haemorrhage Ripasudil has not been found to have any effects to other receptors and enzymes including serine threonine protein kinases",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Ripasudil has high intraocular permeability and works by decreasing intraocular pressure IOP in a dose dependent manner and increasing flow facility The maximum reduction of IOP occurs after 1 to 2 hours",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}